Recent Activity

Loading...

SLNO

Soleno Therapeutics Inc · NASDAQ

Performance

-3.11%

1W

+22.15%

1M

-2.45%

3M

+101.13%

6M

+14.68%

YTD

+973.49%

1Y

Profile

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet, which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California.

Investment Analysis Report: SLNO

Overview

In this investment analysis report, we will delve into the financial statements of SLNO, a company in the Health Technology sector specializing in Pharmaceuticals. We will analyze the Balance Sheets, Income Statements, and Cashflow Statements to gain insights into the company's financial health, growth p...

See more ...

Technical Analysis of SLNO 2024-05-10

Overview:

In analyzing the technical indicators for SLNO over the last 5 days, we will delve into the trends, momentum, volatility, and volume aspects to provide a comprehensive outlook on the possible stock price movement. By examining key indicators such as moving averages, MACD, RSI, Bollinger Bands, and OBV, we aim to offer valuable insights...

See more ...

Recent News & Updates